Webinar | Formulation Development For Scalability: Manufacturing Strategies For Bioavailability-Enhancing Technologies




Date: Wednesday, April 3, 2019
Time: 11am EDT | 8am PDT | 4pm BST | 5pm CEST

Register Now 

Lipid formulation and spray-dried dispersions are widely used, and proven technologies to overcome bioavailability challenges for poorly soluble molecules.  For selecting the most suitable formulation technologies in early-phase development, formulation scientists regard efficacy, safety, bioavailability and stability as their top priorities.  However, an early-phase formulation strategy should also consider scale-up and manufacturing challenges that may arise later in development. 
 
If bioavailability and manufacturing challenges are not addressed in early development, the cost and overall timeline of the project may be negatively impacted.  Therefore, developing a bioavailable formulation that is easy to scale-up with superior dose uniformity is imperative for a product’s success.
 
This webcast will focus on:

  • Formulation development considerations for poorly soluble molecules
  • How to develop scalable formulations using spray drying and softgel technology
  • Strategies to select the appropriate early-phase formulation technology
  • Guidance on bridging early-phase and late-phase considerations in formulation development for scalability and manufacturability

Speakers:

Jon Scrafford
Associate Director, Process Engineering
Catalent Pharma Solutions

Andrew Kenna
Scientist
Catalent Pharma Solutions

Raquel Carvalho PhD.
Group Leader - Product Development
Catalent Pharma Solutions